224 related articles for article (PubMed ID: 22510365)
1. Body mass index and survival after breast cancer diagnosis in Japanese women.
Kawai M; Minami Y; Nishino Y; Fukamachi K; Ohuchi N; Kakugawa Y
BMC Cancer; 2012 Apr; 12():149. PubMed ID: 22510365
[TBL] [Abstract][Full Text] [Related]
2. Anthropometric factors, physical activity, and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women: a case-control study.
Kawai M; Kakugawa Y; Nishino Y; Hamanaka Y; Ohuchi N; Minami Y
Cancer Causes Control; 2013 May; 24(5):1033-44. PubMed ID: 23494727
[TBL] [Abstract][Full Text] [Related]
3. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
4. Alcohol Consumption and Breast Cancer Risk According to Hormone Receptor Status in Japanese Women: A Case-Control Study.
Takizawa Y; Kawai M; Kakugawa Y; Nishino Y; Ohuchi N; Minami Y
Tohoku J Exp Med; 2018 Jan; 244(1):63-73. PubMed ID: 29353824
[TBL] [Abstract][Full Text] [Related]
5. Smoking and survival after breast cancer diagnosis in Japanese women: A prospective cohort study.
Kakugawa Y; Kawai M; Nishino Y; Fukamachi K; Ishida T; Ohuchi N; Minami Y
Cancer Sci; 2015 Aug; 106(8):1066-74. PubMed ID: 26052951
[TBL] [Abstract][Full Text] [Related]
6. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis.
Niraula S; Ocana A; Ennis M; Goodwin PJ
Breast Cancer Res Treat; 2012 Jul; 134(2):769-81. PubMed ID: 22562122
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database-Breast Cancer Registry.
Kawai M; Tomotaki A; Miyata H; Iwamoto T; Niikura N; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Nakamura S; Tokuda Y
Cancer Med; 2016 Jun; 5(6):1328-40. PubMed ID: 26923549
[TBL] [Abstract][Full Text] [Related]
8. Dietary pattern and breast cancer risk in Japanese women: the Japan Public Health Center-based Prospective Study (JPHC Study).
Shin S; Saito E; Inoue M; Sawada N; Ishihara J; Takachi R; Nanri A; Shimazu T; Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Br J Nutr; 2016 May; 115(10):1769-79. PubMed ID: 26997498
[TBL] [Abstract][Full Text] [Related]
9. Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.
Fagherazzi G; Chabbert-Buffet N; Fabre A; Guillas G; Boutron-Ruault MC; Mesrine S; Clavel-Chapelon F
Int J Obes (Lond); 2012 Mar; 36(3):431-9. PubMed ID: 21427693
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancer.
Oudanonh T; Nabi H; Ennour-Idrissi K; Lemieux J; Diorio C
Int J Cancer; 2020 May; 146(10):2736-2745. PubMed ID: 31403177
[TBL] [Abstract][Full Text] [Related]
11. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
12. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women.
; Schoemaker MJ; Nichols HB; Wright LB; Brook MN; Jones ME; O'Brien KM; Adami HO; Baglietto L; Bernstein L; Bertrand KA; Boutron-Ruault MC; Braaten T; Chen Y; Connor AE; Dorronsoro M; Dossus L; Eliassen AH; Giles GG; Hankinson SE; Kaaks R; Key TJ; Kirsh VA; Kitahara CM; Koh WP; Larsson SC; Linet MS; Ma H; Masala G; Merritt MA; Milne RL; Overvad K; Ozasa K; Palmer JR; Peeters PH; Riboli E; Rohan TE; Sadakane A; Sund M; Tamimi RM; Trichopoulou A; Ursin G; Vatten L; Visvanathan K; Weiderpass E; Willett WC; Wolk A; Yuan JM; Zeleniuch-Jacquotte A; Sandler DP; Swerdlow AJ
JAMA Oncol; 2018 Nov; 4(11):e181771. PubMed ID: 29931120
[TBL] [Abstract][Full Text] [Related]
13. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan.
Iwasaki M; Otani T; Inoue M; Sasazuki S; Tsugane S;
Ann Epidemiol; 2007 Apr; 17(4):304-12. PubMed ID: 17174568
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population.
Abubakar M; Sung H; Bcr D; Guida J; Tang TS; Pfeiffer RM; Yang XR
Breast Cancer Res; 2018 Sep; 20(1):114. PubMed ID: 30227867
[TBL] [Abstract][Full Text] [Related]
15. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
Suzuki R; Orsini N; Saji S; Key TJ; Wolk A
Int J Cancer; 2009 Feb; 124(3):698-712. PubMed ID: 18988226
[TBL] [Abstract][Full Text] [Related]
16. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease.
Minicozzi P; Berrino F; Sebastiani F; Falcini F; Vattiato R; Cioccoloni F; Calagreti G; Fusco M; Vitale MF; Tumino R; Sigona A; Budroni M; Cesaraccio R; Candela G; Scuderi T; Zarcone M; Campisi I; Sant M
Eur J Cancer; 2013 Dec; 49(18):3881-8. PubMed ID: 24011933
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer in 2 Large Databases.
Li Z; Tu Y; Wu Q; Wang Z; Li J; Zhang Y; Sun S
Clin Breast Cancer; 2020 Apr; 20(2):e151-e163. PubMed ID: 31551181
[TBL] [Abstract][Full Text] [Related]
18. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.
Caan BJ; Kwan ML; Hartzell G; Castillo A; Slattery ML; Sternfeld B; Weltzien E
Cancer Causes Control; 2008 Dec; 19(10):1319-28. PubMed ID: 18752034
[TBL] [Abstract][Full Text] [Related]
19. Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
Cantini L; Pistelli M; Merloni F; Fontana A; Bertolini I; De Angelis C; Bastianelli L; Della Mora A; Santinelli A; Savini A; Maccaroni E; Diodati L; Falcone A; Berardi R
Clin Breast Cancer; 2020 Feb; 20(1):e89-e98. PubMed ID: 31378534
[TBL] [Abstract][Full Text] [Related]
20. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
